SlideShare a Scribd company logo
1 of 8
Download to read offline
NK603 Regulatory
Status

Annick Pleysier
23 March 2010
Monsanto Company




                   1
Outline

• Where is NK603 in the overall approval process?
• When can we reasonably expect to have NK603 authorised for
  cultivation in the EU?
• How is Monsanto preparing for the Post Market Environmental
  Monitoring of NK603?
• When can we reasonably expect to have NK603 on the market?




                                                                2
Where is NK603 in the overall approval
  process?                 EFSA Completeness check √
                                                                     Member State
                                                 EFSA review √       Consultation √
                                             CRL method validation √

                                                                     Public
NK603 – food, feed, import, cultivation                              Consultation √
NK603 – Art 8(1)(b), 20(1)(b) renewal       Commission Proposal

                                             SCFCAH Vote (Q/M)
  NK603 already authorised
                                               <255
 • for import and processing under Dir.
   2001/18/EC acc. to Commission Decision   Council Decision (Q/M)
   2004/643/EC
 • for use as foods and food ingredients       <255
   under Reg. (EC) No. 258/97 acc. to
   Commission Decision 2005/448/EC           Commission decision
                                                                             3
When can we reasonably expect to have
        NK603 authorised for cultivation in the EU?


                                                    Jun ’09              EFSA opinion
                                                          http://www.efsa.europa.eu/en/scdocs/scdoc/1137.htm
“Within 3 months”, Commission shall submit a                                                              Public
draft of the Decision to the SCFCAH                                                                       Consultation √
(Art 7(1) & 19(1) of Reg. (EC) No. 1829/2003)


Time limit determined by SCFCAH chairman
                                                    Apr ’10 ?    Commission Proposal
“according to the urgency of the matter”
(Art 5(2) of Council Decision 1999/468/EC)

If no Q/M in SCFCAH, Commission forwards
                                                    Jun ’10 ?      SCFCAH Vote (Q/M)
proposal to the Council of Ministers “without
delay” (Art 5(4) of Council Decision 1999/468/EC)                      <255
and the Council of Ministers may act “within 3
months” (Art 35(2) of Reg. (EC) No. 1829/2003)      Oct ’10 ?   Council Decision (Q/M)
If no Q/M in Council of Ministers, Commission                          <255
adopts the decision (no legal time limit)
                                                    Nov ’10 ?     Commission decision
                                                                                                                  4
How is Monsanto preparing for the PMEM of
NK603?
The EFSA opinion concluded that Case-Specific Monitoring was not required for NK603,
so only General Surveillance (GS) needs to be implemented.

GS will include:
• Activities in cooperation with other companies under EuropaBio Monitoring WG
   umbrella and in collaboration with EU and MS
     –   Harmonisation of farmer questionnaire
     –   Identification, selection of appropriate existing networks and reporting process

•   Monsanto’s stewardship activities
     –   Monitoring of peer-reviewed scientific literature
          • Since first placing on the market (2001 in US) until Nov 2009: 44 publications on NK603
             (via ISI WOK), overall confirming the conclusions of the original risk assessment
     –   Monsanto’s adverse effects reporting system
     –   Monsanto’s issue alerts system
          • e.g. Austrian mouse study on NK603 x MON 810 and de Vendomois/Seralini et al.
             paper on NK603, (MON 863 and MON 810)
          • Monsanto response on Monsanto website - For the record :
             http://www.monsanto.com/products/techandsafety/fortherecord_science/default.asp

                                                                                                  5
When can we reasonably expect to have
NK603 on the market?
                                     …          2011     …
                                                Launch
NK603 registration
EU

               Variety registration
               Member States and EU catalogue

         Roundup formulation registration
         Member States




                                                             6
Conclusion

• NK603 has an EFSA opinion and entered the comitology process
• If timelines laid out in EU legislation are respected, it is reasonable
  to expect NK603 authorisation at the end of 2010
• Monsanto is preparing for General Surveillance of NK603 in
  cooperation with EuropaBio, in collaboration with EU and MS and
  internally, as part of its stewardship activities
• If the EU NK603 event authorisation is in place and a MS has a
  Roundup formulation for the appropriate use and the appropriate
  NK603 variety registered by end 2010/beginning 2011, then NK603
  may be launched next year in that MS



                                                                            7
Thank you!




             8

More Related Content

More from Monsanto

More from Monsanto (20)

J Costa
J CostaJ Costa
J Costa
 
Y Devos
Y DevosY Devos
Y Devos
 
L Buzdugan
L BuzduganL Buzdugan
L Buzdugan
 
E Rodriguez Cerezo
E Rodriguez CerezoE Rodriguez Cerezo
E Rodriguez Cerezo
 
D Mathews
D MathewsD Mathews
D Mathews
 
Y Devos
Y Devos Y Devos
Y Devos
 
R Albajes
R AlbajesR Albajes
R Albajes
 
N Muelleder
N MuellederN Muelleder
N Muelleder
 
J Soukup
J SoukupJ Soukup
J Soukup
 
A Verschwele
A VerschweleA Verschwele
A Verschwele
 
T Thieme
T ThiemeT Thieme
T Thieme
 
D Sammons
D SammonsD Sammons
D Sammons
 
B Real & J Maillet Mezeray
B Real & J Maillet MezerayB Real & J Maillet Mezeray
B Real & J Maillet Mezeray
 
R de Prado
R de PradoR de Prado
R de Prado
 
N Muelleder
N Muelleder N Muelleder
N Muelleder
 
M Roettele
M RoetteleM Roettele
M Roettele
 
J Soteres
J SoteresJ Soteres
J Soteres
 
J Clarke
J ClarkeJ Clarke
J Clarke
 
A Dhaussy
A DhaussyA Dhaussy
A Dhaussy
 
J Orson
J OrsonJ Orson
J Orson
 

Recently uploaded

Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
WSO2
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 

Recently uploaded (20)

Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu SubbuApidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
 
A Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source MilvusA Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source Milvus
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024
 
ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challenges
 
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
 
MS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsMS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectors
 

A Pleysier

  • 1. NK603 Regulatory Status Annick Pleysier 23 March 2010 Monsanto Company 1
  • 2. Outline • Where is NK603 in the overall approval process? • When can we reasonably expect to have NK603 authorised for cultivation in the EU? • How is Monsanto preparing for the Post Market Environmental Monitoring of NK603? • When can we reasonably expect to have NK603 on the market? 2
  • 3. Where is NK603 in the overall approval process? EFSA Completeness check √ Member State EFSA review √ Consultation √ CRL method validation √ Public NK603 – food, feed, import, cultivation Consultation √ NK603 – Art 8(1)(b), 20(1)(b) renewal Commission Proposal SCFCAH Vote (Q/M) NK603 already authorised <255 • for import and processing under Dir. 2001/18/EC acc. to Commission Decision Council Decision (Q/M) 2004/643/EC • for use as foods and food ingredients <255 under Reg. (EC) No. 258/97 acc. to Commission Decision 2005/448/EC Commission decision 3
  • 4. When can we reasonably expect to have NK603 authorised for cultivation in the EU? Jun ’09 EFSA opinion http://www.efsa.europa.eu/en/scdocs/scdoc/1137.htm “Within 3 months”, Commission shall submit a Public draft of the Decision to the SCFCAH Consultation √ (Art 7(1) & 19(1) of Reg. (EC) No. 1829/2003) Time limit determined by SCFCAH chairman Apr ’10 ? Commission Proposal “according to the urgency of the matter” (Art 5(2) of Council Decision 1999/468/EC) If no Q/M in SCFCAH, Commission forwards Jun ’10 ? SCFCAH Vote (Q/M) proposal to the Council of Ministers “without delay” (Art 5(4) of Council Decision 1999/468/EC) <255 and the Council of Ministers may act “within 3 months” (Art 35(2) of Reg. (EC) No. 1829/2003) Oct ’10 ? Council Decision (Q/M) If no Q/M in Council of Ministers, Commission <255 adopts the decision (no legal time limit) Nov ’10 ? Commission decision 4
  • 5. How is Monsanto preparing for the PMEM of NK603? The EFSA opinion concluded that Case-Specific Monitoring was not required for NK603, so only General Surveillance (GS) needs to be implemented. GS will include: • Activities in cooperation with other companies under EuropaBio Monitoring WG umbrella and in collaboration with EU and MS – Harmonisation of farmer questionnaire – Identification, selection of appropriate existing networks and reporting process • Monsanto’s stewardship activities – Monitoring of peer-reviewed scientific literature • Since first placing on the market (2001 in US) until Nov 2009: 44 publications on NK603 (via ISI WOK), overall confirming the conclusions of the original risk assessment – Monsanto’s adverse effects reporting system – Monsanto’s issue alerts system • e.g. Austrian mouse study on NK603 x MON 810 and de Vendomois/Seralini et al. paper on NK603, (MON 863 and MON 810) • Monsanto response on Monsanto website - For the record : http://www.monsanto.com/products/techandsafety/fortherecord_science/default.asp 5
  • 6. When can we reasonably expect to have NK603 on the market? … 2011 … Launch NK603 registration EU Variety registration Member States and EU catalogue Roundup formulation registration Member States 6
  • 7. Conclusion • NK603 has an EFSA opinion and entered the comitology process • If timelines laid out in EU legislation are respected, it is reasonable to expect NK603 authorisation at the end of 2010 • Monsanto is preparing for General Surveillance of NK603 in cooperation with EuropaBio, in collaboration with EU and MS and internally, as part of its stewardship activities • If the EU NK603 event authorisation is in place and a MS has a Roundup formulation for the appropriate use and the appropriate NK603 variety registered by end 2010/beginning 2011, then NK603 may be launched next year in that MS 7